Journal
PSYCHOPHARMACOLOGY
Volume 237, Issue 10, Pages 3149-3159Publisher
SPRINGER
DOI: 10.1007/s00213-020-05600-1
Keywords
Major depressive disorder; Benzamide; Selenium; Serotonin; Tail suspension test
Categories
Funding
- Universidade Federal de Pelotas (UFPel)
- Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES/PROAP)
- Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) [420386/2018-1, 438384/2018-0]
- Fundacao de Amparo a Pesquisa do Estado do Rio Grande do Sul (FAPERGS) fellowship
Ask authors/readers for more resources
Rationale Major depressive disorder is a psychiatric disorder that requires considerable attention, since it dramatically impairs the quality of life of the sufferers. The available treatments do not have the efficacy needed, often presenting several side effects. Organoselenium compounds and benzamides have presented some pharmacological properties, among them an antidepressant-like effect. Objectives and methods This study evaluated the antidepressant-like effect ofN-(3-(phenylselanyl)prop-2-yn-1-yl)benzamide (SePB), an organoselenium compound containing a benzamide moiety, on the forced swimming test (FST) and the tail suspension test (TST) in mice, as well as the involvement of the serotonergic system in its effect. Results SePB, tested after different times (15-120 min) and doses (1-50 mg/kg, intragastrically (i.g.)), reduced immobility of male mice during FST and TST, without changing locomotor activity in the open-field test (OFT), demonstrating its antidepressant-like effect. SePB (10 mg/kg) also produced an antidepressant-like effect in female mice in the TST. The preadministration of the serotonin (5-HT) depletor p-chlorophenylalanine (pCPA; 100 mg/kg, intraperitoneal route (i.p.) once daily for 4 days) prevented the anti-immobility effect of SePB, indicating that the serotonergic system is involved in the SePB antidepressant-like effect. The preadministration of the selective serotonergic receptor antagonists WAY100635 (0.1 mg/kg, subcutaneous route (s.c.), a selective 5-HT(1A)receptor antagonist), ketanserin (1 mg/kg, i.p., a 5-HT(2A/2C)receptor antagonist), and ondansetron (1 mg/kg, i.p., a selective 5-HT(3)receptor antagonist) also prevented the anti-immobility effect of SePB, demonstrating that these receptors are involved in the antidepressant-like effect of SePB. Conclusion The search for new antidepressants drugs is a noteworthy goal. This study has described a new compound with an antidepressant-like effect, whose mechanism of action is related to modulation of the serotonergic system.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available